Novel paradigm for treating vasculopathy in systemic sclerosis: Vascular progenitor cells and statins Monique HinchcliffJohn Varga Invited Commentary 03 June 2007 Pages: 1 - 3
The molecular pathogenesis of Chlamydia-induced arthritis: Where do we stand? Markus RihlHenning Zeidler Invited Commentary 03 June 2007 Pages: 4 - 5
Nitric oxide synthases and osteoarthritis Jose U. ScherMichael H. PillingerSteven B. Abramson OriginalPaper 03 June 2007 Pages: 9 - 15
Monitoring cartilage turnover Nadine Charni-Ben TabassiPatrick Garnero OriginalPaper 03 June 2007 Pages: 16 - 24
The utility of nutraceuticals in the treatment of osteoarthritis Tracy M. FrechDaniel O. Clegg OriginalPaper 03 June 2007 Pages: 25 - 30
Treatment of osteoarthritis with anakinra Imran IqbalRoy Fleischmann OriginalPaper 03 June 2007 Pages: 31 - 35
Cardiovascular risk, hypertension, and NSAIDs William B. White OriginalPaper 03 June 2007 Pages: 36 - 43
New directions in osteoporosis therapy: Intravenous ibandronate and denosumab Gim Gee TengNivedita M. PatkarKenneth G. Saag Clinical Trials Report 03 June 2007 Pages: 47 - 49
Cost-effectiveness modeling research of pharmacologic therapy to prevent osteoporosis-related fractures John T. Schousboe OriginalPaper 03 June 2007 Pages: 50 - 56
Kyphoplasty and vertebroplasty: How good is the evidence? Fergus E. McKiernan OriginalPaper 03 June 2007 Pages: 57 - 65
Osteoporosis in men: Pathophysiology and treatment Luigi GennariJohn P. Bilezikian OriginalPaper 03 June 2007 Pages: 71 - 77
Emerging consensus on prevention and treatment of glucocorticoid-induced osteoporosis Juliet E. Compston OriginalPaper 03 June 2007 Pages: 78 - 84
Not just calcium and vitamin D: Other nutritional considerations in osteoporosis Beth KitchinSarah L. Morgan OriginalPaper 03 June 2007 Pages: 85 - 92
